H.R. 679: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

H.R. 679 is a federal bill in the 119th Congress. Currently, the abortion pill mifepristone can be dispensed by certified retail pharmacies and through mail order, following a change made by the Food and Drug Administration (FDA) in January 2023. Before this change, mifepristone had to be dispensed in… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.